We treated 139 patients with primary lung cancers by CO-60 from 1964 to 1971.The size of single dose was 600R twice a week and therefore 1200R in a week-dose.The total of dosage used was from 6000R to 8400R over a period from 5 to 7 weeks in most cases.
As control, 148 patients treated by daily dose of 200R six times per week were compared with this trial.
The consequence of our studies was evaluated by crude survival rate, median survival months and tumor regression rate.The procedure of 600R twice a week has a better therapeutic effect than control.
As to side effects we checked local and general side effects.In regard to skin reactions, erythema and dry reactions occured in most cases, but moist reactions occured in only 2 cases.
Pulmonary pneumonitis has been seen in about 60% of cases between the end of and 3 months after the treatment.In the cases of delivering 8000R or more, pneumonitis occured in almost all the cases within 2 months from the beginning of treatment.But, administration of medicines eliminated severe symptoms due to pneumonitis or fibrosis.
White cells were examined once a week in all cases, 3000/mm3 of white cells were regarded as a minimal for further irradiation.White cell counts of more than 4000 were 54.9%, 4000 to 3000 40.7%, and below 3000, 4.4% respectively.
Thrombocytes below 100, 000/mm3 were seen only in a few, and red cells showed no appreciable change.
Tumors were regressed approximateoy the same degree by both types of treatments without conspicuous side effects.
In addition, in our procedure anti-tumor drugs and hyperbaric oxygen therapy can be utilized relatively easily during unirradiated time.
View full abstract